Kun Ding is a Bronx, New York based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Kun Ding is MD219271 for Ophthalmology in Oregon. Kun Ding is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Kun Ding speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Gender:
Male
Practice Address:
234 E 149th St Ste 8-20, Bronx, New York, 10451-5504
Phone:
718-579-5874
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1922637503
NPI Enumeration Date:
05 Apr, 2020
NPI Last Update On:
18 Mar, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kun Ding are as mentioned below.
License Number
Specialization
State
Status
MD219271
Ophthalmology
Oregon
Primary
Student in an Organized Health Care Education/Training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
234 E 149th St Ste 8-20, Bronx, New York
Zip:
10451-5504
Phone Number:
718-579-5874
Fax Number:
--
Patients can reach Kun Ding at 234 E 149th St Ste 8-20, Bronx, New York or can call to book an appointment on 718-579-5874. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.